AstraZeneca has agreed an up-to-$1.86bn collaboration with machine-learning biotech Insitro to use AI to discover treatments for fatty liver and myocardial disease. AstraZeneca will pay a $40m upfront fee. Insitro will combine its and AstraZeneca’s d

2026-10-15

AstraZeneca has agreed an up-to-$1.86bn collaboration with machine-learning biotech Insitro to use AI to discover treatments for fatty liver and myocardial disease. AstraZeneca will pay a $40m upfront fee. Insitro will combine its and AstraZeneca’s data to study disease mechanisms; if successful, Insitro could receive up to $1.46bn in additional payments plus potential royalties on any drugs. California-based Insitro has prior drug-development deals with Eli Lilly and Bristol Myers Squibb and is backed by Andreessen Horowitz, BlackRock and Temasek.

Other News
2026-10-15

US Treasury auction for the 8 weeks ending October 15 - winning interest rate allocation percentage: 50.08%, previous value: 8.93%.

2026-10-15

1. Trump again criticizes the Federal Reserve: The terrible Fed deliberately keeps interest rates too high. 2. New plan for strike against Iran developed: According to CNN, citing multiple US officials familiar with the matter, the US military has d